Margaret M. FitzPatrick, Director at AN2 Therapeutics, Inc. (ANTX), bought 8,610 shares at $1.18 ($10K) on 2025-05-28, disclosed to the SEC on 2025-05-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.